Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Cataract Refract Surg ; 30(1): 195-9, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14967290

RESUMO

PURPOSE: To investigate preoperative and postoperative prophylactic treatment with different pharmacological agents before flap cutting and exposure to a diffuse lamellar keratitis (DLK) causative agent. SETTING: Magill Research Center for Vision Correction, Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina, USA. METHODS: The study comprised 48 eyes of 24 Dutch-belted rabbits. Three days before a corneal flap was cut and the corneal interface was exposed to Pseudomonas aeruginosa lipopolysaccharide endotoxin, a DLK causative agent, the eyes were randomly assigned to treatment with a mast-cell stabilizer, a nonsteroidal antiinflammatory drug (NSAID), or a corticosteroid or left without treatment as controls. The treatment was maintained throughout the 1-week follow-up. Slitlamp examinations and photographs were performed at 1, 3, 5, and 7 days; DLK was graded by a masked observer from 0 (no DLK) to IV. Corneal interface scrapings were performed in selected eyes on day 7. RESULTS: At the end of the follow-up, 36 eyes were available for evaluation. At 1 week, 100% of the control eyes and the eyes treated with the mast-cell stabilizer developed DLK; in the NSAID-treated and corticosteroid-treated eyes, the DLK rate was 86% and 70%, respectively. At 1 day, the severity of DLK was significantly lower in eyes treated with the mast-cell stabilizer (0.44) and at 7 days, it was significantly lower in corticosteroid-treated eyes (0.3) than in the control group (1.5 and 1.4, respectively) (P<.05, Wilcoxon test). Corneal interface scraping from an eye with grade III DLK showed numerous inflammatory cells. CONCLUSIONS: Preoperative and postoperative treatment with corticosteroids significantly reduced the severity of DLK compared to the untreated control eyes in this animal model. Treatment with a mast-cell stabilizer and an NSAID had less effect on the postoperative course of DLK.


Assuntos
Anti-Inflamatórios não Esteroides/administração & dosagem , Glucocorticoides/administração & dosagem , Ceratite/prevenção & controle , Cetorolaco de Trometamina/administração & dosagem , Nedocromil/administração & dosagem , Prednisolona/análogos & derivados , Prednisolona/administração & dosagem , Animais , Córnea/efeitos dos fármacos , Córnea/patologia , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Ceratite/induzido quimicamente , Ceratite/patologia , Lipopolissacarídeos/toxicidade , Cuidados Pós-Operatórios , Cuidados Pré-Operatórios , Pseudomonas aeruginosa , Coelhos , Retalhos Cirúrgicos
2.
J Cataract Refract Surg ; 29(5): 1014-8, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12781292

RESUMO

We report the results of laser in situ keratomileusis (LASIK) in a 51-year-old woman with subsequent mycobacterial keratitis diagnosed by staining with acid-fast and fluorochrome methods, a technique known to have good sensitivity and specificity for mycobacteria. A rapid diagnosis was made without waiting for cultures, and treatment was instituted, including tapering of topical steroids and appropriate antibiotic therapy. The result was preservation of the LASIK flap and a favorable visual outcome at 6 months.


Assuntos
Úlcera da Córnea/diagnóstico , Infecções Oculares Bacterianas/diagnóstico , Ceratomileuse Assistida por Excimer Laser In Situ/efeitos adversos , Infecções por Mycobacterium não Tuberculosas/diagnóstico , Mycobacterium chelonae/isolamento & purificação , Complicações Pós-Operatórias , Amicacina/administração & dosagem , Técnicas Bacteriológicas , Ciprofloxacina/administração & dosagem , Claritromicina/administração & dosagem , Úlcera da Córnea/tratamento farmacológico , Úlcera da Córnea/microbiologia , Técnicas de Diagnóstico Oftalmológico , Quimioterapia Combinada/administração & dosagem , Infecções Oculares Bacterianas/tratamento farmacológico , Infecções Oculares Bacterianas/etiologia , Feminino , Humanos , Indicadores e Reagentes , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Infecções por Mycobacterium não Tuberculosas/etiologia , Miopia/cirurgia , Coloração e Rotulagem/métodos , Tobramicina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA